Innovating Works

FUNDACIO INSTITUT D'INVESTIGACIO EN CIENCIES DE LA SALUT GERMANS TRIASI PUJOL

Inactiva
Mostrando 1 al 20 de 28 resultados
HYPIEND: Understanding and preventing the impact of endocrine disruptors on the hypothalamus pituitary axis i... FUNDACIO EURECAT tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-ENVHLTH-02 Exposure to multiple endocrine disrupting chemicals (EDC) is an environmental insult that interferes with the development and function of th...
2023-12-11 - 2028-12-31 | Financiado
IMMUTOL: ADVANCED ANTIGEN-SPECIFIC DENDRITIC CELL-BASED THERAPY TO RE-ESTABLISH TOLERANCE IN IMMUNE-MEDIATED... FONDAZIONE TELETHON ETS tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-two-stage Autoimmune diseases are currently treated with immunosuppressive and supportive therapies, which dampen inflammation, but do not stop the ca...
2023-04-14 - 2027-04-30 | Financiado
END-VOC: ENDING COVID 19 VARIANTS OF CONCERN THROUGH COHORT STUDIES: END-VOC UNIVERSITY COLLEGE LONDON tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-CORONA-01 The END-VOC consortium will support the European and global response to the COVID-19 pandemic and Variants of Concern (VOC) through well cha...
2022-08-17 - 2025-04-30 | Financiado
UNDINE: The human genetic and immunological determinants of the clinical manifestations of SARS-CoV-2 infect... AARHUS UNIVERSITET tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 "The consequences of SARS-CoV-2 exposure range from a lack of infection to lethal COVID-19. This immense inter-individual clinical variabili...
2022-05-20 - 2026-05-31 | Financiado
ISIDORe: Integrated Services for Infectious Disease Outbreak Research EUROPEAN RESEARCH INFRASTRUCTURE ON HIGHLY PATHOGENIC AGENTS tramitó un HORIZON EUROPE: HORIZON-INFRA-2021-EMERGENCY-02 The ISIDORe consortium, made of the capacities of European ESFRI infrastructures and coordinated networks, proposes to assemble the largest...
2022-02-09 - 2025-07-31 | Financiado
EPSN 2021: EUROPEAN PERFORMING SCIENCE NIGHT FUNDACION EPICA LA FURA DELS BAUS tramitó un H2020: H2020-MSCA-NIGHT-2020bis The theatre company La Fura dels Baus (established in 1979) started a creative foundation Fundacion Epica to transfer -as informal training-...
2021-05-05 - 2021-10-31 | Financiado
PLASTICHEAL: Innovative tools to study the impact and mode of action of micro and nanoplastics on human health t... UNIVERSITAT AUTÒNOMA DE BARCELONA tramitó un H2020: H2020-SC1-BHC-2018-2020 The exponential increase in the production/use of plastic translates into a parallel increase of environmental plastic-waste that is continu...
2021-01-29 - 2025-03-31 | Financiado
SMA-TB: A novel Stratified Medicine Algorithm to predict treatment responses to host directed therapy in TB... FUNDACIO INSTITUT D'INVESTIGACIO EN CIENCIES DE LA SALUT GERMANS TRIASI PUJOL tramitó un H2020: H2020-SC1-BHC-2018-2020 Tuberculosis (TB) is a chronic, life-threatening infectious disease which poses a tremendous challenge for physicians, researchers and Healt...
2019-12-06 - 2024-12-31 | Financiado
RECOGNISED: Retinal and cognitive dysfunction in type 2 diabetes unraveling the common pathways and identificat... FUNDACIO HOSPITAL UNIVERSITARI VALL HEBRON - INSTITUT DE RECERCA tramitó un H2020: H2020-SC1-BHC-2018-2020 In recent years there is mounting evidence that type 2 diabetes (T2D) is associated with cognitive impairment and dementia, which can be con...
2019-11-21 - 2024-12-31 | Financiado
INsTRuCT: INnovative Training in Myeloid Regulatory Cell Therapy KLINIKUM DER UNIVERSITAET REGENSBURG tramitó un H2020: H2020-MSCA-ITN-2019 Cell therapy is an active area of immunological research and represents a highly innovative and rapidly expanding sector of pharmaceutical i...
2019-08-19 - 2024-06-30 | Financiado
iPC: individualizedPaediatricCure Cloud based virtual patient models for precision paediatric oncology TECHNIKON FORSCHUNGS UND PLANUNGSGESELLSCHAFT MBH tramitó un H2020: H2020-SC1-DTH-2018-2020 Effective personalized medicine for paediatric cancers must address a multitude of challenges, including domain-specific challenges. To over...
2018-12-19 - 2023-11-30 | Financiado
INNOVA4TB: Innovation in Tuberculosis FUNDACIO INSTITUT D'INVESTIGACIO EN CIENCIES DE LA SALUT GERMANS TRIASI PUJOL tramitó un H2020: H2020-MSCA-RISE-2018 The objective of INNOVA4TB is to enhance and strengthen the collaborative research among sectors and to form a network aimed to perform high...
2018-10-04 - 2024-06-30 | Financiado
RESTORE: NEURONAL SELF RENEWAL BY ANTIGEN SPECIFIC TOLERIZATION IN MULTIPLE SCLEROSIS REINSTALLING THE BALANC... Multiple sclerosis (MS) is an inflammatory neurodegenerative disease of the central nervous system for which no cure is currently available....
2017-11-21 - 2023-06-30 | Financiado
ELBA: European Liquid Biopsies Academy Towards widespread clinical application of blood based diagnosti... STICHTING AMSTERDAM UMC tramitó un H2020: H2020-MSCA-ITN-2017 Liquid biopsies have been heralded as a game changer in cancer management, with blood tests offering a minimally invasive, safe, and sensiti...
2017-08-30 - 2022-09-30 | Financiado
ChiLTERN: Children s Liver Tumour European Research Network THE UNIVERSITY OF BIRMINGHAM tramitó un H2020: H2020-PHC-2014-2015 Liver cancer in the paediatric population is rare with an incidence approximately 1-1.5 per million population. The commonest tumour seen in...
2015-12-07 - 2021-12-31 | Financiado
EUthyroid: Towards the elimination of iodine deficiency and preventable thyroid related diseases in Europe UNIVERSITATSMEDIZIN GREIFSWALD KORPERSCHAFT DES OFFENTLICHEN RECHTS tramitó un H2020: H2020-PHC-2014-2015 Despite the fact that iodine deficiency (ID) can easily be prevented by iodine fortification of table salt, industrial salt and cattle food,...
2015-04-08 - 2018-05-31 | Financiado
TBVAC2020: TBVAC2020 Advancing novel and promising TB vaccine candidates from discovery to preclinical and ear... STICHTING TUBERCULOSIS VACCINE INITIATIVE tramitó un H2020: H2020-PHC-2014-2015 The TBVAC2020 proposal builds on the highly successful and long-standing collaborations in subsequent EC-FP5-, FP6- and FP7-funded TB vaccin...
2014-12-03 - 2019-06-30 | Financiado
EMI-TB: Eliciting Mucosal Immunity to Tuberculosis ST GEORGES HOSPITAL MEDICAL SCHOOL tramitó un H2020: H2020-PHC-2014-2015 Tuberculosis (TB) is a global health problem, killing 1.5 million of people every year. The only currently available vaccine, Mycobacterium...
2014-11-26 - 2019-06-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.